Do Venetoclax tablets and Venetoclax tablets work the same?

Venetoclax (Venetoclax) tablets are Venetoclax. Venacla is the generic name marketed in China under the trade name of venekra. The common names of venetoclax listed overseas are venetoclax, etc. They are sold under the trade names of Venclexta, Venclyxto.

Venetoclax is a cancer drug used to treat adults with the following blood cancers, including chronic lymphocytic leukemia (CLL), acute myeloid leukemia (AML), and others. It can be used withobinutuzumab in patients who have not previously received treatment for CLL, or with rituximab in patients who have received at least one previous treatment. Patients with specific genetic alterations (17p deletions or TP53 mutations) or those who have failed to respond to chemotherapy combined with immunotherapy and B-cell receptor pathway inhibitors can also be treated with venetoclax. For AML, venetoclax is used in combination with azacitidine or decitabine in adults who cannot undergo intensive chemotherapy.

The original drug of Venetoclax on the domestic market has been included in the scope of Class B medical insurance, and the price of each box of 100mg*14 tablets may be around RMB 5,000. The Turkish version of Venaclaoriginal drug, specifications100mg*112 tablets, sold overseas, costs around RMB 10,000 per box (the price may fluctuate due to exchange rates), which is even more expensive. Cheaper generic drugs are also sold overseas, and their pharmaceutical ingredients are basically the same as those of the original drugs. The price of a box of 100mg*120 tablets produced by a Bangladeshi pharmaceutical factory is around RMB 4,000 (prices may fluctuate due to exchange rates).